IPP Bureau
Imfinzi plus chemotherapy tripled patient survival at 3 years
By IPP Bureau - September 20, 2021
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
Novartis’ Kisqali data indicates longest median survival in advanced breast cancer
By IPP Bureau - September 20, 2021
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
CDSCO approves Exablate 4000 for patients living with Parkinson’s disease
By IPP Bureau - September 20, 2021
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
Academy of Family Physicians partner with Eka Care to build a digital platform
By IPP Bureau - September 20, 2021
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
India to resume export of Covid-19 vaccines from October
By IPP Bureau - September 20, 2021
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
By IPP Bureau - September 20, 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
By IPP Bureau - September 20, 2021
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
.jpg "India extends concession on life-saving Covid-19 drugs till December 2021")
India extends concession on life-saving Covid-19 drugs till December 2021
By IPP Bureau - September 18, 2021
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
Samhita and Cipla collaborate to study the role of pharmacists in healthcare
By IPP Bureau - September 18, 2021
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
Union Minister Jitendra Singh launch free telemedicine facility
By IPP Bureau - September 18, 2021
Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India
Roche receives positive CHMP opinion for Gavreto
By IPP Bureau - September 18, 2021
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
Pharmexcil exhibition and conference on Sept 21-22
By IPP Bureau - September 18, 2021
The event will include an exhibition and sector-wise sessions for two days with participation by officials from the Ministry of Commerce, export promotion councils and members of the industry
Zydus Cadila receives final nod for anti-depressant
By IPP Bureau - September 18, 2021
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
Apollo Hospital Chennai completes India’s first robotic bariatric surgery
By IPP Bureau - September 18, 2021
This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports
Excision receives U.S. FDA clearance for first-in-human CRISPR Phase I/II trail for HIV
By IPP Bureau - September 18, 2021
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
